Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Detection of residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer (preSANO): a prospective multicentre, diagnostic cohort study.
Noordman BJ, Spaander MCW, Valkema R, Wijnhoven BPL, van Berge Henegouwen MI, Shapiro J, Biermann K, van der Gaast A, van Hillegersberg R, Hulshof MCCM, Krishnadath KK, Lagarde SM, Nieuwenhuijzen GAP, Oostenbrug LE, Siersema PD, Schoon EJ, Sosef MN, Steyerberg EW, van Lanschot JJB; SANO study group. Noordman BJ, et al. Among authors: hulshof mccm. Lancet Oncol. 2018 Jul;19(7):965-974. doi: 10.1016/S1470-2045(18)30201-8. Epub 2018 Jun 1. Lancet Oncol. 2018. PMID: 29861116
NEOadjuvant therapy monitoring with PET and CT in Esophageal Cancer (NEOPEC-trial).
van Heijl M, Omloo JM, van Berge Henegouwen MI, Busch OR, Tilanus HW, Bossuyt PM, Hoekstra OS, Stoker J, Hulshof MC, van der Gaast A, Nieuwenhuijzen GA, Bonenkamp HJ, Plukker JT, Bilgen EJ, Ten Kate FJ, Boellaard R, Pruim J, Sloof GW, van Lanschot JJ. van Heijl M, et al. BMC Med Phys. 2008 Jul 31;8:3. doi: 10.1186/1756-6649-8-3. BMC Med Phys. 2008. PMID: 18671847 Free PMC article.
Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.
Hirdes MM, van Hooft JE, Wijrdeman HK, Hulshof MC, Fockens P, Reerink O, van Oijen MG, van der Tweel I, Vleggaar FP, Siersema PD. Hirdes MM, et al. Gastrointest Endosc. 2012 Aug;76(2):267-74. doi: 10.1016/j.gie.2012.04.442. Epub 2012 Jun 12. Gastrointest Endosc. 2012. PMID: 22695208 Clinical Trial.
Patterns of recurrence after surgery alone versus preoperative chemoradiotherapy and surgery in the CROSS trials.
Oppedijk V, van der Gaast A, van Lanschot JJ, van Hagen P, van Os R, van Rij CM, van der Sangen MJ, Beukema JC, Rütten H, Spruit PH, Reinders JG, Richel DJ, van Berge Henegouwen MI, Hulshof MC. Oppedijk V, et al. J Clin Oncol. 2014 Feb 10;32(5):385-91. doi: 10.1200/JCO.2013.51.2186. Epub 2014 Jan 13. J Clin Oncol. 2014. PMID: 24419108 Clinical Trial.
Reply to E. C. Smyth et al.
Hulshof MC, Oppedijk V, van der Gaast A. Hulshof MC, et al. J Clin Oncol. 2014 Sep 20;32(27):3081-2. doi: 10.1200/JCO.2014.56.3866. Epub 2014 Jul 28. J Clin Oncol. 2014. PMID: 25071131 No abstract available.
189 results